ATHE Stock Summary and Trading Ideas (Alterity Therapeutics Limited - American Depositary Shares | NASDAQ:ATHE)

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

Alterity Therapeutics Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol ATHE.

As of December 20, 2024, ATHE stock price climbed to $2.20 with 26,531 million shares trading.

ATHE has a beta of 2.47, meaning it tends to be more sensitive to market movements. ATHE has a correlation of 0.09 to the broad based SPY ETF.

ATHE has a market cap of $19.23 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ATHE traded as high as $12.30 and as low as $1.00.

ATHE has underperformed the market in the last year with a return of -17.3%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ATHE shares. However, ATHE has outperformed the market in the last 3 month and 2 week periods, returning +78.9% and +2.3%, while SPY returned +4.4% and -2.4%, respectively. This indicates ATHE has been having a stronger performance recently.

ATHE support price is $1.92 and resistance is $2.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATHE shares will trade within this expected range on the day.